Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 601 to 625 of 797

Sort by

Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	1 February 2016	1 February 2016
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated	TA377	27 January 2016	27 January 2016
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy	TA378	27 January 2016	27 January 2016
Nintedanib for treating idiopathic pulmonary fibrosis	TA379	27 January 2016	27 January 2016
Panobinostat for treating multiple myeloma after at least 2 previous treatments	TA380	27 January 2016	27 January 2016
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)	TA382	27 January 2016	27 January 2016
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	26 January 2016	26 January 2016
Guidance on the use of imatinib for chronic myeloid leukaemia	TA70	22 October 2003	21 January 2016
Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears	TA369	16 December 2015	16 December 2015
Bortezomib for previously untreated mantle cell lymphoma	TA370	16 December 2015	16 December 2015
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis	TA373	16 December 2015	16 December 2015
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy	TA374	16 December 2015	16 December 2015
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C	TA365	25 November 2015	25 November 2015
Vortioxetine for treating major depressive episodes	TA367	25 November 2015	25 November 2015
Ledipasvir–sofosbuvir for treating chronic hepatitis C	TA363	25 November 2015	25 November 2015
Tolvaptan for treating autosomal dominant polycystic kidney disease	TA358	28 October 2015	28 October 2015
Idelalisib for treating chronic lymphocytic leukaemia	TA359	28 October 2015	28 October 2015
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)	TA362	28 October 2015	28 October 2015
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy	TA352	26 August 2015	26 August 2015
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)	TA353	26 August 2015	26 August 2015
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism	TA354	26 August 2015	26 August 2015
Naloxegol for treating opioid‑induced constipation	TA345	22 July 2015	22 July 2015
Aflibercept for treating diabetic macular oedema	TA346	22 July 2015	22 July 2015
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer	TA347	22 July 2015	22 July 2015
Everolimus for preventing organ rejection in liver transplantation	TA348	22 July 2015	22 July 2015

Results per page

10
25
50
All